Partial Inhibition of Adipose Tissue Lipolysis Improves Glucose Metabolism and Insulin Sensitivity Without Alteration of Fat Mass

• Amandine Girousse,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Geneviève Tavernier,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Carine Valle,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Cedric Moro,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Niklas Mejhert,

  Affiliation Department of Medicine, Karolinska Institute at Karolinska Hospital, Huddinge, Stockholm, Sweden

  ⨯
• Anne-Laure Dinel,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Marianne Houssier,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Balbine Roussel,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Aurèle Besse-Patin,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Marion Combes,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Lucile Mir,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Laurent Monbrun,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Véronic Bézaire,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Bénédicte Prunet-Marcassus,

  Affiliation Physiogenex, Prologue Biotech, Labège-Innopole, France

  ⨯
• Aurélie Waget,

  Affiliations University of Toulouse, UMR1048, Paul Sabatier University, France, INSERM, UMR1048,Team 2, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France

  ⨯
• Isabelle Vila,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Sylvie Caspar-Bauguil,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France, Toulouse University Hospitals, Laboratory of Clinical Biochemistry, Toulouse, France

  ⨯
• Katie Louche,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Marie-Adeline Marques,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Aline Mairal,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Marie-Laure Renoud,

  Affiliations University of Toulouse, UMR1048, Paul Sabatier University, France, INSERM, UMR1048, Team 1, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France

  ⨯
• Jean Galitzky,

  Affiliations University of Toulouse, UMR1048, Paul Sabatier University, France, INSERM, UMR1048, Team 1, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France

  ⨯
• Cecilia Holm,

  Affiliation Department of Experimental Medical Science, Lund University, Lund, Sweden

  ⨯
• Etienne Mouisel,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Claire Thalamas,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France, Toulouse University Hospitals, INSERM, Clinical Investigation Center, Toulouse, France

  ⨯
• Nathalie Viguerie,

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

  ⨯
• Thierry Sulpice,

  Affiliation Physiogenex, Prologue Biotech, Labège-Innopole, France

  ⨯
• Rémy Burcelin,

  Affiliations University of Toulouse, UMR1048, Paul Sabatier University, France, INSERM, UMR1048,Team 2, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France

  ⨯
• Peter Arner,

  Affiliation Department of Medicine, Karolinska Institute at Karolinska Hospital, Huddinge, Stockholm, Sweden

  ⨯
•  [ ... ],
• Dominique Langin

  * E-mail: dominique.langin@inserm.fr

  Affiliations INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France, Toulouse University Hospitals, Laboratory of Clinical Biochemistry, Toulouse, France

  ⨯
• [ view all ]
• [ view less ]